Vaccine shows promise for pancreatic cancer, study finds

by

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.

Leave A Comment

Your email address will not be published. Required fields are marked *